These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 24088310

  • 1. Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
    Tsujita E, Yamashita Y, Takeishi K, Maeda T, Takaki S, Mori N, Aisaka Y, Furukawa Y, Shirabe K, Ishida T, Maehara Y.
    Hepatogastroenterology; 2013; 60(128):2048-54. PubMed ID: 24088310
    [Abstract] [Full Text] [Related]

  • 2. Effect of sustained virological response to interferon therapy for hepatitis C to the hepatectomy for primary hepatocellular carcinoma.
    Tsujita E, Maeda T, Kayashima H, Harada N, Tsutsui S, Matsuda H, Kinjo N, Ikeda Y, Morita M, Ishida T.
    Hepatogastroenterology; 2015; 62(137):157-63. PubMed ID: 25911888
    [Abstract] [Full Text] [Related]

  • 3. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
    Sanefuji K, Kayashima H, Iguchi T, Sugimachi K, Yamashita Y, Yoshizumi T, Soejima Y, Nishizaki T, Taketomi A, Maehara Y.
    J Surg Oncol; 2009 Jan 01; 99(1):32-7. PubMed ID: 18985618
    [Abstract] [Full Text] [Related]

  • 4. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Uenishi T, Nishiguchi S, Tanaka S, Yamamoto T, Takemura S, Kubo S.
    J Surg Oncol; 2008 Oct 01; 98(5):358-62. PubMed ID: 18646001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
    Shirabe K, Sugimachi K, Harada N, Kayashima H, Maeda T, Tsujita E, Minagawa R, Kajiyama K, Yoshiya S, Maehara Y.
    Anticancer Res; 2015 Dec 01; 35(12):6963-9. PubMed ID: 26637923
    [Abstract] [Full Text] [Related]

  • 7. Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.
    Ishikawa T, Higuchi K, Kubota T, Seki K, Honma T, Yoshida T, Kamimura T.
    Hepatogastroenterology; 2012 Dec 01; 59(114):529-32. PubMed ID: 22024226
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
    Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y, Ueshima K.
    Oncology; 2007 Dec 01; 72 Suppl 1():132-8. PubMed ID: 18087194
    [Abstract] [Full Text] [Related]

  • 10. Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
    Nagaoki Y, Aikata H, Nakano N, Shinohara F, Nakamura Y, Hatooka M, Morio K, Kan H, Fujino H, Kobayashi T, Fukuhara T, Masaki K, Ono A, Nakahara T, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Imamura M, Takahashi S, Kawakami Y, Ochi H, Chayama K, Hiroshima Liver Study Group.
    J Gastroenterol Hepatol; 2016 May 01; 31(5):1009-15. PubMed ID: 26584407
    [Abstract] [Full Text] [Related]

  • 11. Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor.
    Kanogawa N, Ogasawara S, Chiba T, Saito T, Motoyama T, Suzuki E, Ooka Y, Tawada A, Kanda T, Mikami S, Azemoto R, Kaiho T, Shinozaki M, Ohtsuka M, Miyazaki M, Yokosuka O.
    J Gastroenterol Hepatol; 2015 Jul 01; 30(7):1197-204. PubMed ID: 25682720
    [Abstract] [Full Text] [Related]

  • 12. Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy.
    Tanaka S, Tamori A, Takemura S, Hamano G, Ito T, Kawada N, Kubo S.
    Am Surg; 2017 Nov 01; 83(11):1246-1255. PubMed ID: 29183527
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.
    J Gastroenterol Hepatol; 2011 Sep 01; 26(9):1380-8. PubMed ID: 21884247
    [Abstract] [Full Text] [Related]

  • 14. Is hepatic resection for recurrent or persistent hepatocellular carcinoma justified?
    Kishi Y, Saiura A, Yamamoto J, Koga R, Seki M, Morimura R, Yoshioka R, Kokudo N, Yamaguch T.
    Hepatogastroenterology; 2012 Oct 01; 59(119):2255-9. PubMed ID: 23435140
    [Abstract] [Full Text] [Related]

  • 15. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?
    Chan AC, Chan SC, Chok KS, Cheung TT, Chiu DW, Poon RT, Fan ST, Lo CM.
    Liver Transpl; 2013 Apr 01; 19(4):411-9. PubMed ID: 23447460
    [Abstract] [Full Text] [Related]

  • 16. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Ikeda K, Kawamura Y, Kobayashi M, Kominami Y, Fujiyama S, Sezaki H, Hosaka T, Akuta N, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Kumada H.
    Dig Dis Sci; 2017 Oct 01; 62(10):2932-2942. PubMed ID: 28884320
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.